Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)
Condition(s):COVID-19Last Updated:September 21, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):COVID-19Last Updated:September 21, 2023Terminated
Condition(s):HemophiliaLast Updated:September 20, 2016Unknown status
Condition(s):Hemophilia ALast Updated:April 4, 2016Completed
Condition(s):Covid19Last Updated:August 17, 2021Completed
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:October 20, 2020Recruiting
Condition(s):Diffuse Large B Cell Lymphoma; Central Nervous System LymphomaLast Updated:September 23, 2021Recruiting
Condition(s):Sars-CoV2; COVIDLast Updated:November 22, 2021Completed
Condition(s):Severe Hemophilia A Without Inhibitor; Joint BleedLast Updated:March 5, 2024Recruiting
Condition(s):Large B-cell Diffuse Lymphoma of TestisLast Updated:March 10, 2023Active, not recruiting
Condition(s):Cardiothoracic Surgery; Vascular SurgeryLast Updated:June 6, 2014Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.